Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO 2014 Congress, Madrid

ESMO 2014, the world's premier congress in medical oncology will be taking place in Madrid from the 26 - 30 September 2014. The congress will attract an international community of experts around the main theme: 'Precision Medicine in Cancer Care.’

This is the ultimate goal of ESMO 2014 and we count on our Industry Partners active in oncology to help us again further our science and improve the lives of patients through continued education.

Fast Facts: ESMO 2012 Congress

  • 16 202 participants, 127 countries
  • 4879.5 m² exhibition space, 105 exhibitors
  • 433 guest faculty
  • 149 sessions, 33 topics
  • 2220 submitted abstracts

How can I participate in 2014?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate your presence at our congress.Contact the ESMO Events Sponsorship Team for more details and we look forward to hearing from you!

Who has already signed up?

ESMO gratefully acknowledges the valuable contribution of the following organisations in the ESMO 2014 Congress through their presence in the exhibition hall, organisation of sponsored sessions, or via sponsorship activities (As of September 2014):

Companies

  • AbbVie
  • Agendia NV
  • Amgen (Europe) GmbH
  • Angelini Acraf S.p.A
  • Astellas Europe Pharma Ltd
  • AstraZeneca
  • Barrington James
  • Bavarian Nordic Inc.
  • Baxter Deutschland GmbH
  • Bayer HealthCare Pharmaceuticals
  • Biocartis NV
  • Boehringer Ingelheim
  • Bristol-Myers Squibb Europe
  • Caris Life Sciences
  • CeGat GmbH
  • Celgene International Sarl
  • Dove Medical Press Ltd
  • Elsevier Ltd.
  • Excemed
  • Exelixis, Inc.
  • F.Hoffmann-La Roche Ltd
  • Fresenius Kabi GmbH
  • Genomic Health
  • GlaxoSmithKline
  • Global Oncology Academy
  • Helsinn Healthcare SA
  • Hospira Ltd.
  • Imedex, Inc.
  • Intrasense
  • Ipsen Innovation
  • Janssen Pharmaceutica NV
  • Keosys Medical Imaging
  • Lexicon
  • Lilly Oncology
  • MBL International
  • Medac Gesellschaft für klinische Spezialpräparate m.b.H
  • Median Technologies
  • Merck Serono
  • MSD
  • Myriad Genetics GmbH
  • NanoString Technologies
  • Nordic Pharma
  • Norgine Pharmaceuticals Limited
  • Novartis Oncology
  • Novocure
  • Nutricia
  • Ockham Oncology
  • OncoDNA
  • OncoGenex Pharmaceuticals, Inc.
  • Oncotherm GmbH
  • Otsuka Pharmaceutical Europe Ltd.
  • Oxford University Press
  • Paxman Coolers Ltd.
  • Peregrine Pharmaceuticals Inc.
  • PerkinElmer
  • Pfizer Oncology
  • Pharmadab d.o.o.
  • PharmaMar
  • Pierre Fabre Medicament
  • Pivotal SL
  • Prime Oncology
  • Qiagen GmbH
  • Research To Practice
  • Sandoz International GmbH
  • Sanofi Oncology
  • Simbec-Orion
  • Sirtex Medical Europe GmbH
  • Sotio a.s.
  • Springer Healthcare Education
  • Sysmex Europe GmbH
  • Takeda Pharmaceuticals Int., Inc.
  • Taiho Pharma USA Inc.
  • Teva Pharmaceuticals Europe BV
  • The Angiogenesis Foundation
  • Varian Medical System
  • Wisepress Online Bookshop Ltd.
  • Xi'an Good Doctor Medical Science and Technology Co., Ltd. 

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings